Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-07-20 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: EAUNES (31600), Haute-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ARNAUD TAILLIS : revenue, balance sheet and financial ratios
PHARMACIE ARNAUD TAILLIS is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in EAUNES (31600),
this company of category PME
shows in 2025 a net income positive of 197 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ARNAUD TAILLIS (SIREN 841907421)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
196 670 €
207 258 €
191 876 €
155 995 €
158 008 €
154 278 €
-34 212 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE ARNAUD TAILLIS generates positive net income of 197 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
196 670 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 70%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
69.804%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.763%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1127.427
532.577
325.506
209.627
141.326
96.019
69.804
Financial autonomy
7.03
13.661
20.371
27.902
34.717
42.803
49.763
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
69.82025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-12 pts over 3 years
In 2025, the debt ratio of PHARMACIE ARNAUD TAILLIS (69.80) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.76%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE ARNAUD TAILLIS (49.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 129.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
126.127
129.712
138.491
116.268
122.582
130.704
129.829
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
129.832025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch
In 2025, the liquidity ratio of PHARMACIE ARNAUD TAILLIS (129.83) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE ARNAUD TAILLIS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ARNAUD TAILLIS is estimated at
3 124 126 €
(range 2 120 046€ - 4 902 184€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2120k€3124k€4902k€
3 124 126 €Range: 2 120 046€ - 4 902 184€
NAF 5 année 2025
Valuation method used
Net Income Multiple
196 670 €
×
15.9x
=3 124 126 €
Range: 2 120 047€ - 4 902 184€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ARNAUD TAILLIS with other companies in the same sector:
Frequently asked questions about PHARMACIE ARNAUD TAILLIS
What is the revenue of PHARMACIE ARNAUD TAILLIS ?
The revenue of PHARMACIE ARNAUD TAILLIS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE ARNAUD TAILLIS profitable?
Yes, PHARMACIE ARNAUD TAILLIS generated a net profit of 197 k€ in 2025.
Where is the headquarters of PHARMACIE ARNAUD TAILLIS ?
The headquarters of PHARMACIE ARNAUD TAILLIS is located in EAUNES (31600), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE ARNAUD TAILLIS ?
The tax return of PHARMACIE ARNAUD TAILLIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ARNAUD TAILLIS operate?
PHARMACIE ARNAUD TAILLIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart